Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Ray-Coquard

Showing results (1-10 of 546) with videos related to

Pageof 55
Sort By:
Bulletin Du Cancer|March 30, 2004
[Docetaxel and ovarian cancer]Isabelle Ray-Coquard
Future Oncology (London, England)|November 8, 2013
Biology of ovarian cancer and trabectedin mechanism of actionIsabelle Ray-Coquard
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 5, 2011
An increasing role for trabectedin in gynecological cancers: efficacy in uterine sarcomasIsabelle Ray-Coquard
Expert Review of Anticancer Therapy|September 19, 2018
Management of relapsed ovarian cancer in routine clinical practice: a case studyIsabelle Ray-Coquard
Future Oncology (London, England)|October 13, 2017
Trabectedin mechanism of action and platinum resistance: molecular rationaleIsabelle Ray-Coquard
Future Oncology (London, England)|September 26, 2022
Driving forward: beneficial treatment strategies for leiomyosarcoma patientsIsabelle Ray-Coquard
Clinical Advances in Hematology & Oncology : H&O|January 19, 2012
Maintenance therapy in the treatment of sarcomaIsabelle Ray-Coquard
Current Opinion in Oncology|May 19, 2021
Gynecological sarcomas: literature review of 2020Brunhilde Hanvic, Isabelle Ray-Coquard
Current Opinion in Oncology|May 31, 2018
Gynecological sarcomas: what's new in 2018, a brief review of published literatureJustine Gantzer, Isabelle Ray-Coquard
Nature Reviews. Clinical Oncology|July 4, 2012
Targeted therapies: pazopanib for soft-tissue sarcoma: a PALETTE of data emergesIsabelle Ray-Coquard, David Thomas
Pageof 55

Showing results (1-10 of 546) with videos related to

Sort By:
Pageof 55
Bulletin Du Cancer|March 30, 2004
[Docetaxel and ovarian cancer]Isabelle Ray-Coquard
Future Oncology (London, England)|November 8, 2013
Biology of ovarian cancer and trabectedin mechanism of actionIsabelle Ray-Coquard
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 5, 2011
An increasing role for trabectedin in gynecological cancers: efficacy in uterine sarcomasIsabelle Ray-Coquard
Expert Review of Anticancer Therapy|September 19, 2018
Management of relapsed ovarian cancer in routine clinical practice: a case studyIsabelle Ray-Coquard
Future Oncology (London, England)|October 13, 2017
Trabectedin mechanism of action and platinum resistance: molecular rationaleIsabelle Ray-Coquard
Future Oncology (London, England)|September 26, 2022
Driving forward: beneficial treatment strategies for leiomyosarcoma patientsIsabelle Ray-Coquard
Clinical Advances in Hematology & Oncology : H&O|January 19, 2012
Maintenance therapy in the treatment of sarcomaIsabelle Ray-Coquard
Current Opinion in Oncology|May 19, 2021
Gynecological sarcomas: literature review of 2020Brunhilde Hanvic, Isabelle Ray-Coquard
Current Opinion in Oncology|May 31, 2018
Gynecological sarcomas: what's new in 2018, a brief review of published literatureJustine Gantzer, Isabelle Ray-Coquard
Nature Reviews. Clinical Oncology|July 4, 2012
Targeted therapies: pazopanib for soft-tissue sarcoma: a PALETTE of data emergesIsabelle Ray-Coquard, David Thomas
Pageof 55